Related Experiment Video
Updated: Jun 27, 2026
08:44
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
Short hairpin RNAs against eotaxin or interleukin-5 decrease airway eosinophilia and hyper-responsiveness in a murine
Hsin-Ying Huang1, Chen-Chen Lee, Bor-Luen Chiang
1Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.
The Journal of Gene Medicine
|December 20, 2008
Summary
Short hairpin RNA (shRNA) targeting eotaxin and interleukin-5 (IL-5) effectively reduced airway inflammation in a mouse model of asthma. This approach shows potential for developing new therapies for eosinophilic airway diseases.
Area of Science:
- Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- Eosinophilia is central to asthma pathogenesis, driven by eotaxin and interleukin-5 (IL-5).
- Previous work demonstrated IL-5 shRNA inhibited airway inflammation in a murine asthma model.
- This study investigates eotaxin shRNA and combined eotaxin/IL-5 shRNA effects on asthma.
Purpose of the Study:
- To evaluate the role of eotaxin shRNA in asthma.
- To assess the synergistic effect of eotaxin and IL-5 shRNAs.
- To investigate therapeutic potential in an ovalbumin-induced asthma model.
Main Methods:
- Utilized lentivirus-delivered short hairpin RNAs (shRNAs) to target eotaxin and/or IL-5 expression.
- Administered shRNAs via intra-tracheal delivery in a murine model of ovalbumin-induced asthma.
Main Results:
- Eotaxin shRNA (eoSEC3.3) significantly reduced airway hyper-responsiveness and cellular infiltration.
- Eotaxin shRNA normalized eotaxin and IL-5 levels in bronchoalveolar lavage fluid.
- Combined IL-5 and eotaxin shRNAs (IL5SEC4 + eoSEC3.3) also ameliorated asthma symptoms.
Conclusions:
- Local lentiviral delivery of IL-5 and eotaxin shRNAs effectively moderates airway inflammation.
- This strategy offers a potential therapeutic tool for T helper 2 cell-mediated inflammation and eosinophilia.
- Highlights the potential for shRNA-based clinical therapies targeting key asthma mediators.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...